consort healthcare (tameside) plc
consort healthcare (tameside) plc Company Information
Company Number
06165353
Website
-Registered Address
c/o albany spc services ltd, 3-5 charlotte street, manchester, M1 4HB
Industry
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Telephone
-
Next Accounts Due
June 2024
Group Structure
View All
Shareholders
consort healthcare (tameside) holdings ltd 100%
consort healthcare (tameside) intermediate ltd 0%
consort healthcare (tameside) plc Estimated Valuation
The estimated valuation range for consort healthcare (tameside) plc, derived from financial data as of December 2022 and the most recent industry multiples, is between £0 to £1.7m
consort healthcare (tameside) plc Estimated Valuation
The estimated valuation range for consort healthcare (tameside) plc, derived from financial data as of December 2022 and the most recent industry multiples, is between £0 to £1.7m
consort healthcare (tameside) plc Estimated Valuation
The estimated valuation range for consort healthcare (tameside) plc, derived from financial data as of December 2022 and the most recent industry multiples, is between £0 to £1.7m
Get a detailed valuation report, edit figures and unlock valuation multiples.
Consort Healthcare (tameside) Plc AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Consort Healthcare (tameside) Plc Overview
Consort Healthcare (tameside) Plc is a live company located in manchester, M1 4HB with a Companies House number of 06165353. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in March 2007, it's largest shareholder is consort healthcare (tameside) holdings ltd with a 100% stake. Consort Healthcare (tameside) Plc is a established, small sized company, Pomanda has estimated its turnover at £4.5m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Consort Healthcare (tameside) Plc Health Check
Pomanda's financial health check has awarded Consort Healthcare (Tameside) Plc a 3 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
4 Weak
Size
annual sales of £4.5m, make it larger than the average company (£2.5m)
£4.5m - Consort Healthcare (tameside) Plc
£2.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 5%, show it is growing at a similar rate (4.5%)
5% - Consort Healthcare (tameside) Plc
4.5% - Industry AVG
Production
with a gross margin of 18.5%, this company has a higher cost of product (43.8%)
18.5% - Consort Healthcare (tameside) Plc
43.8% - Industry AVG
Profitability
an operating margin of -88.5% make it less profitable than the average company (5.8%)
-88.5% - Consort Healthcare (tameside) Plc
5.8% - Industry AVG
Employees
with 36 employees, this is above the industry average (21)
- Consort Healthcare (tameside) Plc
21 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Consort Healthcare (tameside) Plc
- - Industry AVG
Efficiency
resulting in sales per employee of £125.4k, this is equally as efficient (£125.8k)
- Consort Healthcare (tameside) Plc
£125.8k - Industry AVG
Debtor Days
it gets paid by customers after 43 days, this is earlier than average (56 days)
43 days - Consort Healthcare (tameside) Plc
56 days - Industry AVG
Creditor Days
its suppliers are paid after 94 days, this is slower than average (32 days)
94 days - Consort Healthcare (tameside) Plc
32 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Consort Healthcare (tameside) Plc
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 2 weeks, this is less cash available to meet short term requirements (26 weeks)
2 weeks - Consort Healthcare (tameside) Plc
26 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 102.5%, this is a higher level of debt than the average (54.6%)
102.5% - Consort Healthcare (tameside) Plc
54.6% - Industry AVG
consort healthcare (tameside) plc Credit Report and Business Information
Consort Healthcare (tameside) Plc Competitor Analysis
Perform a competitor analysis for consort healthcare (tameside) plc by selecting its closest rivals and benchmarking them against 12 key performance metrics.
consort healthcare (tameside) plc Ownership
CONSORT HEALTHCARE (TAMESIDE) PLC group structure
Consort Healthcare (Tameside) Plc has no subsidiary companies.
Ultimate parent company
SUN LIFE (US) HOLDCO 2020 INC
#0116416
2 parents
CONSORT HEALTHCARE (TAMESIDE) PLC
06165353
consort healthcare (tameside) plc directors
Consort Healthcare (Tameside) Plc currently has 2 directors. The longest serving directors include Ms Stephanie Exell (Sep 2019) and Mr William Morris (Aug 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Stephanie Exell | United Kingdom | 46 years | Sep 2019 | - | Director |
| Mr William Morris | England | 44 years | Aug 2023 | - | Director |
CONSORT HEALTHCARE (TAMESIDE) PLC financials
Consort Healthcare (Tameside) Plc's latest turnover from December 2022 is £4.5 million and the company has net assets of -£2.3 million. According to their latest financial statements, we estimate that Consort Healthcare (Tameside) Plc has 36 employees and maintains cash reserves of £4.4 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Jun 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 4,514,000 | 4,709,000 | 4,827,000 | 3,891,000 | 4,033,000 | 3,756,000 | 3,640,000 | 3,693,000 | 3,693,000 | 3,819,000 | 3,587,000 | 3,981,000 | 14,674,000 | 64,484,000 | 24,226,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 3,681,000 | 3,627,000 | 3,656,000 | 3,226,000 | 3,309,000 | 3,040,000 | 2,911,000 | 2,954,000 | 2,954,000 | 2,883,000 | 2,879,000 | 2,883,000 | 13,425,000 | 63,790,000 | 24,063,000 |
| Gross Profit | 833,000 | 1,082,000 | 1,171,000 | 665,000 | 724,000 | 716,000 | 729,000 | 739,000 | 739,000 | 936,000 | 708,000 | 1,098,000 | 1,249,000 | 694,000 | 163,000 |
| Admin Expenses | 4,828,000 | 1,551,000 | 991,000 | 523,000 | 582,000 | 559,000 | 581,000 | 523,000 | 523,000 | 514,000 | 287,000 | 682,000 | 855,000 | 504,000 | 138,000 |
| Operating Profit | -3,995,000 | -469,000 | 180,000 | 142,000 | 142,000 | 157,000 | 148,000 | 216,000 | 216,000 | 422,000 | 421,000 | 416,000 | 394,000 | 190,000 | 25,000 |
| Interest Payable | 5,954,000 | 4,708,000 | 5,588,000 | 6,084,000 | 7,478,000 | 6,688,000 | 5,231,000 | 5,511,000 | 5,511,000 | 6,313,000 | 6,440,000 | 6,543,000 | 6,585,000 | 6,292,000 | 4,800,000 |
| Interest Receivable | 7,779,000 | 5,384,000 | 5,977,000 | 6,054,000 | 6,075,000 | 5,683,000 | 5,645,000 | 6,021,000 | 6,021,000 | 6,716,000 | 6,688,000 | 6,677,000 | 6,749,000 | 6,510,000 | 4,867,000 |
| Pre-Tax Profit | -2,170,000 | 207,000 | 569,000 | 112,000 | -1,261,000 | -848,000 | 562,000 | 726,000 | 726,000 | 825,000 | 669,000 | 550,000 | 558,000 | 408,000 | 92,000 |
| Tax | 388,000 | -39,000 | -108,000 | -21,000 | 240,000 | 162,000 | -126,000 | -142,000 | -142,000 | -144,000 | -173,000 | -157,000 | -148,000 | -114,000 | -26,000 |
| Profit After Tax | -1,782,000 | 168,000 | 461,000 | 91,000 | -1,021,000 | -686,000 | 436,000 | 584,000 | 584,000 | 681,000 | 496,000 | 393,000 | 410,000 | 294,000 | 66,000 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 150,000 | 662,000 | 662,000 | 585,000 | 636,000 | 891,000 | 0 | 0 | 0 |
| Retained Profit | -1,782,000 | 168,000 | 461,000 | 91,000 | -1,021,000 | -686,000 | 286,000 | -78,000 | -78,000 | 96,000 | -140,000 | -498,000 | 410,000 | 294,000 | 66,000 |
| Employee Costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Number Of Employees | |||||||||||||||
| EBITDA* | -3,995,000 | -469,000 | 180,000 | 142,000 | 142,000 | 157,000 | 148,000 | 216,000 | 216,000 | 425,000 | 422,000 | 416,000 | 394,000 | 190,000 | 26,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Jun 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,000 | 4,000 | 4,000 | 7,000 | 7,000 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,596,000 |
| Debtors (Due After 1 year) | 74,636,000 | 76,047,000 | 77,848,000 | 79,418,000 | 81,720,000 | 84,156,000 | 86,181,000 | 88,173,000 | 88,173,000 | 89,218,000 | 89,721,000 | 97,323,000 | 97,245,000 | 84,780,000 | 23,736,000 |
| Total Fixed Assets | 74,636,000 | 76,047,000 | 77,848,000 | 79,418,000 | 81,720,000 | 84,156,000 | 86,181,000 | 88,173,000 | 88,173,000 | 89,218,000 | 89,724,000 | 97,327,000 | 97,249,000 | 84,787,000 | 28,339,000 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7,546,000 | 47,154,000 |
| Trade Debtors | 535,000 | 367,000 | 55,000 | 17,000 | 7,551,000 | 7,025,000 | 7,003,000 | 6,937,000 | 6,941,000 | 7,000 | 7,117,000 | 30,000 | 7,000 | 9,000 | 26,000 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 10,460,000 | 9,398,000 | 8,435,000 | 8,433,000 | 622,000 | 254,000 | 102,000 | 67,000 | 63,000 | 7,278,000 | 61,000 | 67,000 | 94,000 | 289,000 | 1,267,000 |
| Cash | 4,386,000 | 7,438,000 | 7,307,000 | 6,888,000 | 6,880,000 | 8,891,000 | 10,992,000 | 9,563,000 | 9,563,000 | 9,878,000 | 8,912,000 | 8,501,000 | 8,818,000 | 5,277,000 | 4,930,000 |
| misc current assets | 2,823,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5,466,000 | 17,355,000 |
| total current assets | 18,204,000 | 17,203,000 | 15,797,000 | 15,338,000 | 15,053,000 | 16,170,000 | 18,097,000 | 16,567,000 | 16,567,000 | 17,163,000 | 16,090,000 | 8,598,000 | 8,919,000 | 18,587,000 | 70,732,000 |
| total assets | 92,840,000 | 93,250,000 | 93,645,000 | 94,756,000 | 96,773,000 | 100,326,000 | 104,278,000 | 104,740,000 | 104,740,000 | 106,381,000 | 105,814,000 | 105,925,000 | 106,168,000 | 103,374,000 | 99,071,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 951,000 | 410,000 | 441,000 | 39,000 | 84,000 | 288,000 | 126,000 | 371,000 | 371,000 | 68,000 | 529,000 | 67,000 | 117,000 | 81,000 | 43,000 |
| Group/Directors Accounts | 3,335,000 | 1,824,000 | 314,000 | 309,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 89,750,000 | 4,644,000 | 3,885,000 | 3,987,000 | 4,315,000 | 4,229,000 | 4,054,000 | 3,998,000 | 3,998,000 | 5,154,000 | 4,275,000 | 3,797,000 | 3,948,000 | 870,000 | 1,383,000 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 1,087,000 | 993,000 | 1,035,000 | 1,118,000 | 1,066,000 | 601,000 | 1,966,000 | 1,295,000 | 1,295,000 | 1,091,000 | 745,000 | 1,526,000 | 1,038,000 | 1,589,000 | 482,000 |
| total current liabilities | 95,123,000 | 7,871,000 | 5,675,000 | 5,453,000 | 5,465,000 | 5,118,000 | 6,146,000 | 5,664,000 | 5,664,000 | 6,313,000 | 5,549,000 | 5,390,000 | 5,103,000 | 2,540,000 | 1,908,000 |
| loans | 0 | 0 | 88,639,000 | 90,433,000 | 92,529,000 | 95,408,000 | 97,646,000 | 98,876,000 | 98,876,000 | 99,790,000 | 100,083,000 | 100,213,000 | 100,245,000 | 100,424,000 | 97,047,000 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 85,880,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 85,880,000 | 88,639,000 | 90,433,000 | 92,529,000 | 95,408,000 | 97,646,000 | 98,876,000 | 98,876,000 | 99,790,000 | 100,083,000 | 100,213,000 | 100,245,000 | 100,424,000 | 97,047,000 |
| total liabilities | 95,123,000 | 93,751,000 | 94,314,000 | 95,886,000 | 97,994,000 | 100,526,000 | 103,792,000 | 104,540,000 | 104,540,000 | 106,103,000 | 105,632,000 | 105,603,000 | 105,348,000 | 102,964,000 | 98,955,000 |
| net assets | -2,283,000 | -501,000 | -669,000 | -1,130,000 | -1,221,000 | -200,000 | 486,000 | 200,000 | 200,000 | 278,000 | 182,000 | 322,000 | 820,000 | 410,000 | 116,000 |
| total shareholders funds | -2,283,000 | -501,000 | -669,000 | -1,130,000 | -1,221,000 | -200,000 | 486,000 | 200,000 | 200,000 | 278,000 | 182,000 | 322,000 | 820,000 | 410,000 | 116,000 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Jun 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | -3,995,000 | -469,000 | 180,000 | 142,000 | 142,000 | 157,000 | 148,000 | 216,000 | 216,000 | 422,000 | 421,000 | 416,000 | 394,000 | 190,000 | 25,000 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,000 | 1,000 | 0 | 0 | 0 | 1,000 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 388,000 | -39,000 | -108,000 | -21,000 | 240,000 | 162,000 | -126,000 | -142,000 | -142,000 | -144,000 | -173,000 | -157,000 | -148,000 | -114,000 | -26,000 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7,546,000 | -39,608,000 | 47,154,000 |
| Debtors | -181,000 | -526,000 | -1,530,000 | -2,025,000 | -1,542,000 | -1,851,000 | -1,891,000 | 0 | -1,326,000 | -396,000 | -521,000 | 74,000 | 12,268,000 | 60,049,000 | 25,029,000 |
| Creditors | 541,000 | -31,000 | 402,000 | -45,000 | -204,000 | 162,000 | -245,000 | 0 | 303,000 | -461,000 | 462,000 | -50,000 | 36,000 | 38,000 | 43,000 |
| Accruals and Deferred Income | 94,000 | -42,000 | -83,000 | 52,000 | 465,000 | -1,365,000 | 671,000 | 0 | 204,000 | 346,000 | -781,000 | 488,000 | -551,000 | 1,107,000 | 482,000 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | -2,791,000 | -55,000 | 1,921,000 | 2,153,000 | 2,185,000 | 967,000 | 2,339,000 | 74,000 | 1,907,000 | 562,000 | 451,000 | 623,000 | -4,991,000 | -19,220,000 | -71,658,000 |
| Investing Activities | |||||||||||||||
| capital expenditure | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4,596,000 | 4,596,000 |
| cash flow from investments | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 1,511,000 | 1,510,000 | 5,000 | 309,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 85,106,000 | 759,000 | -102,000 | -328,000 | 86,000 | 175,000 | 56,000 | 0 | -1,156,000 | 879,000 | 478,000 | -151,000 | 3,078,000 | -513,000 | 1,383,000 |
| Long term loans | 0 | -88,639,000 | -1,794,000 | -2,096,000 | -2,879,000 | -2,238,000 | -1,230,000 | 0 | -914,000 | -293,000 | -130,000 | -32,000 | -179,000 | 3,377,000 | 97,047,000 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | -85,880,000 | 85,880,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | 1,825,000 | 676,000 | 389,000 | -30,000 | -1,403,000 | -1,005,000 | 414,000 | 510,000 | 510,000 | 403,000 | 248,000 | 134,000 | 164,000 | 218,000 | 67,000 |
| cash flow from financing | 2,562,000 | 186,000 | -1,502,000 | -2,145,000 | -4,196,000 | -3,068,000 | -760,000 | 588,000 | -1,560,000 | 989,000 | 596,000 | -49,000 | 3,063,000 | 3,082,000 | 98,547,000 |
| cash and cash equivalents | |||||||||||||||
| cash | -3,052,000 | 131,000 | 419,000 | 8,000 | -2,011,000 | -2,101,000 | 1,429,000 | 0 | -315,000 | 966,000 | 411,000 | -317,000 | 3,541,000 | 347,000 | 4,930,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -3,052,000 | 131,000 | 419,000 | 8,000 | -2,011,000 | -2,101,000 | 1,429,000 | 0 | -315,000 | 966,000 | 411,000 | -317,000 | 3,541,000 | 347,000 | 4,930,000 |
P&L
December 2022turnover
4.5m
-4%
operating profit
-4m
+752%
gross margin
18.5%
-19.69%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
-2.3m
+3.56%
total assets
92.8m
0%
cash
4.4m
-0.41%
net assets
Total assets minus all liabilities
consort healthcare (tameside) plc company details
company number
06165353
Type
Public limited with Share Capital
industry
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
March 2007
age
17
accounts
Full Accounts
ultimate parent company
previous names
N/A
incorporated
UK
address
c/o albany spc services ltd, 3-5 charlotte street, manchester, M1 4HB
last accounts submitted
December 2022
consort healthcare (tameside) plc Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to consort healthcare (tameside) plc. Currently there are 1 open charges and 0 have been satisfied in the past.
consort healthcare (tameside) plc Companies House Filings - See Documents
| date | description | view/download |
|---|
